Indian public company Plethico sought to expand into the US market through the acquisition of a highly regarded, well-established brand and was advised by Bryan, Garnier & Co on the acquisition of Nasdaq-listed Natrol, Inc.


About Plethico

Plethico Pharmaceuticals Limited (BSE: 532739/BO: PLETHICO) is an herbal/nutraceutical-focused Indian company that engages in the manufacture, marketing and distribution of pharmaceutical and allied healthcare products in India and internationally. It operates in the Commonwealth of Independent States (CIS), Africa, South East Asia, Latin America and certain gulf countries. Plethico was founded in 1991 and has its corporate office in Mumbai, India.

Discover Plethico

Gregg Blake

Investment Banking

Gregg Blake photo

Deal Team

Should you want to know more about this transaction, you can contact one of the team members above

Privacy Preference Center

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }